Divestitures / Spin

Wells Fargo looks to sell its Eastdil Secured real-estate division:…

Wells Fargo looks to sell its Eastdil Secured real-estate division:…

Published 26/07/2018

(Reuters) - Wells Fargo & Co (WFC.N) is exploring a sale of its Eastdil Secured real-estate division, the Wall Street Journal reported on Thursday, citing [more…]

Sainsbury’s says Asda merger could result in some store sell-offs

Sainsbury’s says Asda merger could result in some store sell-offs

Published 30/04/2018

LONDON (Reuters) - Sainsbury’s chief executive Mike Coupe said that it was possible that competition authorities would force some stores to be sold to allow [more…]

U.S. FTC requires Amneal and Impax to divest rights to 10 generic…

U.S. FTC requires Amneal and Impax to divest rights to 10 generic…

Published 27/04/2018

WASHINGTON (Reuters) - The U.S. Federal Trade Commission said on Friday it would require Impax Laboratories Inc and privately held Amneal Pharmaceuticals LLC to divest [more…]

China’s HNA Group to remain a ‘major investor’ in Deutsche Bank:…

China’s HNA Group to remain a ‘major investor’ in Deutsche Bank:…

Published 23/04/2018

BEIJING (Reuters) - China’s HNA Group [HNAIRC.UL] will remain a “major investor” in Deutsche Bank (DBKGn.DE), the aviation-to-financial services conglomerate said in a statement on [more…]

Toshiba still aiming to complete sale of memory chip unit soon

Toshiba still aiming to complete sale of memory chip unit soon

Published 23/04/2018

TOKYO (Reuters) - Toshiba Corp (6502.T) said on Monday it is still aiming to complete the sale of its memory chip business soon, following media [more…]

Elliott adds voice to calls for Whitbread break-up

Elliott adds voice to calls for Whitbread break-up

Published 16/04/2018

(Reuters) - Hedge fund Elliott Advisors has become the second activist investor to call for Whitbread (WTB.L) to split its hotel and coffee shop businesses [more…]

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

Published 16/04/2018

LONDON (Reuters) - Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its oncology business to [more…]

Mylan seeks deal for German Merck’s consumer products unit: sources

Mylan seeks deal for German Merck’s consumer products unit: sources

Published 13/04/2018

FRANKFURT/NEW YORK (Reuters) - Generic drug maker Mylan (MYL.O) is in advanced discussions to acquire Merck KGaA’s (MRCG.DE) consumer health business after other bidders failed [more…]

GSK slims portfolio with sale of rare disease gene therapy drugs

GSK slims portfolio with sale of rare disease gene therapy drugs

Published 12/04/2018

LONDON (Reuters) - GlaxoSmithKline is divesting its rare disease gene therapy drugs to private biotech company Orchard Therapeutics as Chief Executive Emma Walmsley makes good [more…]

Concerns over Hyundai Motor Group overhaul rattle Mobis investors

Concerns over Hyundai Motor Group overhaul rattle Mobis investors

Published 29/03/2018

SEOUL (Reuters) - Worries that Hyundai Motor Group’s planned restructuring will benefit the controlling family ahead of some shareholders have hit Hyundai Mobis Co Ltd [more…]